🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06601985
Active, not recruiting Observational

Exploring the Effect of Colonic J-pouch in Anorectal Preservation Surgery for Ultra-low Rectal Cancer.

NCT06601985 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai 10th People's Hospital
Phase
Observational
Started
2022-12-01
Last updated
2024-09-19

Condition(s) studied

Rectum CancerFaecal IncontinenceFaecal Incontinence with Faecal UrgencyLow Anterior Resection SyndromeLeakage, Anastomotic

Investigational drug(s) / intervention(s)

J-pouch anastomosisdirect anastomosis

J-pouch anastomosis: Patient with ultra-low rectal cancer undergoing Sphincter- preserving surgery with one-stage anastomosis using a colon J-pouch.

direct anastomosis: Patient with ultra-low rectal cancer undergoing Sphincter- preserving surgery with one-stage direct anastomosis.

Study summary

The occurrence of colorectal cancer has increased from the third most common cancer in 2018 to the second most common cancer in 2023. The practice of anal preservation surgery for ultra-low rectal cancer is being adopted gradually. Ultra-low rectal cancer patients who have undergone anal preservation are at an increased risk of developing significant bowel complications. The objective of this study was to examine the relationship between the type of bowel reconstruction following anal preservation surgery, and the subsequent outcomes of bowel function, quality of life and complication rates in patients with ultra-low rectal cancer.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. A confirmed diagnosis of intestinal cancer, with the lower edge of the tumour \<5 cm from the anus or \<3 cm from the dentate line, and treated with anus-preserving surgery; 2. No distant metastasis; 3. Age \>18 years old; 4. Voluntary enrollment in the study and signing of an informed consent. Exclusion Criteria: 1. A combination of severe cardiopulmonary, hepatic, renal, and other underlying diseases with a greater anaesthetic risk (ASA ≥ grade 4); 2. preoperative anal stenosis and anal nonfunction; 3. temporary stoma diversion.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Tenth People's Hospital, Yanchang Road, Jing'an District, Shanghai, China Shanghai Jingan

More Shanghai 10th People's Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06601985 on ClinicalTrials.gov ↗ ← All trials in China